16 August 2023 | Wednesday | News
Lam Yu, CEO of Infinitus Global and Vice Chairman of Infinitus (China), expressed his enthusiasm in his speech, "Infinitus has been deeply involved in the field of Chinese herbal medicine for 31 years, while Jiangnan University is a leading research institution in the area of probiotics in China. We eagerly look forward to the two parties taking the establishment of the center as an opportunity to work together closely, to identify and meet user needs". He ventured that he expects the cooperation to lead to the availability of more high-quality Chinese herbal health products, contributing to the health and happiness of consumers.
Chen Wei, Member of the Chinese Academy of Engineering, President of Jiangnan University and Director-General of the National Engineering Research Center for Functional Food (NERCFF), stated, "The signing of this agreement symbolizes a joint effort that will amplify the complementary advantages of universities and enterprises through a robust alliance. The collaboration aims to exert a more positive and far-reaching impact on the entire industry and on consumer health. It marks a new beginning for our shared vision and launches a new journey to deepen collaboration between educational institutions and businesses."
At the event, both parties signed a cooperation agreement, formally establishing the Infinitus-Jiangnan University Collaborative Innovation Research Center for Chinese Herbal Medicine and Probiotics. The launch ceremony that followed signified the beginning of a new phase of strategic cooperation between Infinitus and Jiangnan University, concentrating on the intersection of Chinese herbal medicine and probiotics.
Li Wenzhi, Research Director of Frontier Technology Research at Infinitus (China), delineated the achievements to date and the anticipated direction of the partnership. He noted, "Over the past six years, we have assembled a complete system for the development and application of functional probiotics, a success that led to the selection and cultivation of three strains and combinations that are compatible with the Chinese population's unique gut flora. The effort has led to the acquisition of eight patents in China and the United States. Going forward, we will focus on devising novel products tailored for Chinese consumers by combining probiotics with Chinese herbal medicine."
For 31 years, Infinitus has been committed to elevating its scientific research capabilities within China. To this end, the company has collaborated with leading institutions and universities both domestically and internationally, building a network of scientific research and innovation, consisting of a central hub supported by multi-party research and technology platforms. This alliance underscores Infinitus' dedication to contributing further to the betterment of public health and fostering a healthy China. It highlights not only the company's impressive competencies in comprehensive scientific research but also strengthens its existing system of scientific research and innovation.